Frontlight ResearchEarly access
Gastric and oesophageal cancer trials in United States
274 trials · From ClinicalTrials.gov, checked 19 November 2026. Ask the study team whether a trial fits you.
- Phase 1Taking peopleNeratinib and Fam-Trastuzumab Deruxtecan in Advanced Gastro-esophageal Cancer Patients
- Where
- Buffalo, Palo Alto, Philadelphia
- Age
- 18 years and over
- People
- 18
- Run by
- Fox Chase Cancer Center
See details and how to joinNCT05274048 - Phase 1Taking peopleEvaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
- Where
- Aurora, Beverly Hills, Boston, Chicago, Duarte, Fairfax, Greenville, Houston, Iowa City, Louisville, Miami, Nashville, New Haven, New York, Orange, Orlando, Port Saint Lucie, Santa Monica, Seattle, Washington D.C.
- Age
- 18 years and over
- People
- 540 worldwide
- Run by
- SystImmune Inc.
See details and how to joinNCT05983432 - No phaseTaking peoplePrehabilitation in High-risk Oncologic Surgery
- Where
- Philadelphia
- Age
- 18 years and over
- People
- 180
- Run by
- Fox Chase Cancer Center
See details and how to joinNCT07638410 - Phase 1/2Taking peopleStudy of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
- Where
- Austin, Grand Rapids, Houston, Huntersville, Miami, Minneapolis, Nashville, Salt Lake City, San Antonio, St Louis
- Age
- 18 years and over
- People
- 159 worldwide
- Run by
- Aulos Bioscience, Inc.
See details and how to joinNCT05267626 - Phase 2Taking peoplePharmacologic Therapies to Mitigate Radiation- Associated Heart Disease
- Where
- Chapel Hill
- Age
- 18 years and over
- People
- 60
- Run by
- UNC Lineberger Comprehensive Cancer Center
See details and how to joinNCT07685938 - Phase 1/2Taking peopleA Phase 1/2 Study of BGB-B2033, Alone or in Combination With Tislelizumab With or Without Bevacizumab, in Participants With Advanced or Metastatic Solid Tumors
- Where
- Birmingham, Duarte, Goodyear, Houston, Nashville, New York, Pittsburgh, Zion
- Age
- 18 years and over
- People
- 630 worldwide
- Run by
- BeOne Medicines
See details and how to joinNCT06427941 · EU 2025-524136-19-00 - No phaseTaking peopleEQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients With Gastrointestinal Cancer.
- Where
- Cleveland
- Age
- 18 years and over
- People
- 200
- Run by
- Case Comprehensive Cancer Center
See details and how to joinNCT06263088 - Phase 1Taking peopleA Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas
- Where
- Atlanta, Cleveland, Duarte, Durham, Fairfax, Grand Rapids, Houston, Los Angeles, Nashville, New Haven, New York, Philadelphia, San Francisco
- Age
- 18 years and over
- People
- 160
- Run by
- EvolveImmune United, Inc
See details and how to joinNCT07217171 - No phaseTaking peopleORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
- Where
- Appleton, Aurora, Birmingham, Boston, Broomall, Chandler, Chapel Hill, Cincinnati, Cleveland, Dallas, East Brunswick, Edinburg, Forth Worth, Grand Rapids, Hollywood, Hot Springs, La Jolla, Lakeland, Lewiston, Myrtle Beach, New Orleans, Newport Beach, New York, Philadelphia, Redwood City, Rochester, Rock Hill, Sacramento, Salt Lake City, San Antonio, Shreveport, Toledo, York
- Age
- 18 years and over
- People
- 2,285 worldwide
- Run by
- Guardant Health, Inc.
See details and how to joinNCT05059444 - Phase 2Taking peopleItraconazole in Combination With Ablation for the Prevention of Esophageal Cancer in Patients With High-risk Barrett's Esophagus
- Where
- Ann Arbor, Chapel Hill, Cleveland, Dallas, Kansas City, St Louis
- Age
- 18 years and over
- People
- 76
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT06732388 - Phase 1/2Taking peopleA Study of 2141-V11 in People With Esophageal, Gastric, or Gastroesophageal Junction Adenocarcinoma
- Where
- Basking Ridge, Commack, Harrison, Middletown, Montvale, New York, Uniondale
- Age
- 18 years and over
- People
- 30
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT07818018 - Phase 1Taking peopleA Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic Cancer
- Where
- Chicago, Dallas, Durham, Milwaukee, New Brunswick, New York, Orange, Santa Monica, Seattle, Westwood, Winston-Salem
- Age
- 18 years and over
- People
- 398 worldwide
- Run by
- Astellas Pharma Global Development, Inc.
See details and how to joinNCT05365581 · EU 2023-504514-29-00 - Phase 2Taking peopleStudy of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid Tumors
- Where
- Baltimore, Columbus, Los Angeles, New York, Philadelphia, Stony Brook
- Age
- 18 years to 64 years
- People
- 257 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06535607 · EU 2025-523947-36-00 - No phaseNot yet taking people in United StatesA Preregistered Multi-Cohort Evaluation of the FATHOM AI System for Molecular Testing Prioritization to Support Clinical Trial Enrollment
- Where
- Boston
- People
- 30,000
- Run by
- Harvard Medical School (HMS and HSDM)
See details and how to joinNCT07814872 - No phaseTaking peopleResilience and Equity in Aging, Cancer, and Health (REACH)
- Where
- Boston
- Age
- 65 years and over
- People
- 147
- Run by
- Dana-Farber Cancer Institute
See details and how to joinNCT04674267 - Phase 1Taking peopleSKL35501 With SKL35502 Imaging in Adults With NTSR1 Positive Advanced Solid Tumors
- Where
- Glen Burnie, Pittsburgh
- Age
- 18 years and over
- People
- 100 worldwide
- Run by
- SK Life Science, Inc.
See details and how to joinNCT07812805 - No phaseTaking peopleRetrospective Review of Esophageal Cancer at MSKCC
- Where
- New York
- Age
- 18 years and over
- People
- 4,000
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT05706558 - Phase 1/2Taking peopleSafety and Preliminary Effectiveness of BNT317, an Investigational Therapy for Advanced Solid Tumors
- Where
- Charleston, Dallas, East Providence, Grand Rapids, Huntersville, Louisville, San Antonio
- Age
- 18 years and over
- People
- 248 worldwide
- Run by
- BioNTech SE
See details and how to joinNCT06750185 - Phase 2Taking peoplePhase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer
- Where
- Chicago
- Age
- 18 years and over
- People
- 21
- Run by
- University of Chicago
See details and how to joinNCT04107077 - Phase 1/2Taking peopleSubstudy 06D: Combination Therapies in Second Line (2L) Gastroesophageal Adenocarcinoma (MK-3475-06D/Keymaker-U06)
- Where
- East Syracuse, Grand Rapids, Houston, Los Angeles, Louisville, New York, Pittsburgh, Tucson
- Age
- 18 years and over
- People
- 210 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06445972 · EU 2023-509306-29-00 - Phase 1/2Taking peopleA Study of IDP-001 in Advanced or Metastatic Solid Tumors
- Where
- Buffalo, Fort Worth, Indianapolis, Lake Success, Los Angeles, Sarasota
- Age
- 18 years and over
- People
- 132
- Run by
- InduPro, Inc.
See details and how to joinNCT07602842 - No phaseTaking peopleSerial MRI Scans During Radiation Therapy
- Where
- Boston
- Age
- 18 years and over
- People
- 149
- Run by
- Dana-Farber Cancer Institute
See details and how to joinNCT04188535 - Phase 1Taking peoplePerioperative FLOT(D) With Personalized Ultrafractionated Stereotactic Adaptive Radiotherapy (PULSAR) in Esophageal Cancer
- Where
- Dallas
- Age
- 18 years and over
- People
- 15
- Run by
- University of Texas Southwestern Medical Center
See details and how to joinNCT07700420 - Phase 2Taking peoplePh II Intraperitoneal Paclitaxel + System Therapy in GI Ca w/Peritoneal Carcinomatosis (STOPGAP-B)
- Where
- Orange
- Age
- 18 years and over
- People
- 55
- Run by
- University of California, Irvine
See details and how to joinNCT07795749 - Phase 2Taking peopleIvonescimab in Comb. With FOLFOX in Advanced HER2 Neg. GEA
- Where
- Boston, Santa Monica
- Age
- 18 years and over
- People
- 40
- Run by
- Massachusetts General Hospital
See details and how to joinNCT07070466